Medicilon Logo
|
search icon search icon language icon contact icon menu icon
Medicilon Logo
|
search icon close search icon language icon contact icon menu icon
CN
Message
Contact Us
Close Button
Back To Top
Online Message×
Click switch
Close Button
Drug Efficacy Evaluation for Common Diseases

Deeply integrate R&D experience, constantly climb the peak of R&D technology, and build an integrated innovation service platform for new drug R&D

Drug Efficacy Evaluation for Common Diseases

Medicilon has established drug efficacy evaluation models covering most major human diseases, providing technical support for drug efficacy screening and clinical translational research.


IO Pharmacodynamic Model Evaluation Platform.webp

IO Pharmacodynamic Model Evaluation Platform

Preclinical models are widely used to evaluate anticancer agents in the drug discovery/development phase and assess combination therapies. Animal tumor models have provided opportunities to investigate the underlying molecular basis of cancer, which spans tumor initiation, growth, metastasis, and mechanisms of therapeutic evasion.

Learn more

Pharmacodynamic Evaluation Model Platform for Inflammatory and Immune Diseases.webp

Pharmacodynamic Evaluation Model Platform for Inflammatory and Immune Diseases

Translational immunology assays and inflammation models that accurately reflect the human immune system are powerful tools to advance your immunology research. Medicilon has developed numerous pharmacology, efficacy, and mechanical actions immunology models to support your drug development.

Learn more

Rodent Cerebrovascular Disease Drug Efficacy Evaluation System.webp

Rodent Cerebrovascular Disease Drug Efficacy Evaluation System

In hypertension, the utility of animal models for improving the understanding of the pathogenesis, prevention, and treatment of hypertension and its comorbidities depends on their validity for representing human forms of hypertension, including responses to therapy.

Learn more

Return